Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Christopher R. Martens & Blair A. Denman & Melissa R. Mazzo & Michael L. Armstrong & Nichole Reisdorph & Matthew B. McQueen & Michel Chonchol & Douglas R. Seals
Nature Communications, doi:10.1038/s41467-018-03421-7
Ano:
2018
Editora:
Springer US
Idioma:
english
Arquivo:
PDF, 633 KB
IPFS:
,
english, 2018